Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,389 | 408 | 99.9% |
| Education | $6.02 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,382 | 55 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $803.23 | 45 | $0 (2021) |
| PFIZER INC. | $503.77 | 36 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $484.10 | 25 | $0 (2021) |
| Novo Nordisk Inc | $463.89 | 26 | $0 (2021) |
| AbbVie, Inc. | $449.77 | 8 | $0 (2019) |
| Allergan, Inc. | $404.88 | 20 | $0 (2020) |
| Lilly USA, LLC | $355.04 | 16 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $312.37 | 13 | $0 (2019) |
| Organogenesis Inc. | $305.81 | 13 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $376.99 | 21 | Lilly USA, LLC ($69.36) |
| 2020 | $1,490 | 81 | AstraZeneca Pharmaceuticals LP ($269.03) |
| 2019 | $1,840 | 87 | AstraZeneca Pharmaceuticals LP ($321.79) |
| 2018 | $2,175 | 105 | AstraZeneca Pharmaceuticals LP ($414.55) |
| 2017 | $2,513 | 115 | AstraZeneca Pharmaceuticals LP ($363.17) |
All Payment Transactions
409 individual payment records from CMS Open Payments — Page 17 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/25/2017 | AstraZeneca Pharmaceuticals LP | BEVESPI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Respiratory | ||||||
| 01/25/2017 | AbbVie, Inc. | Androgel (Drug) | Food and Beverage | In-kind items and services | $20.26 | General |
| Category: Endocrinology | ||||||
| 01/24/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $9.85 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/23/2017 | AstraZeneca Pharmaceuticals LP | BEVESPI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $10.75 | General |
| Category: Respiratory | ||||||
| 01/19/2017 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $11.68 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 01/17/2017 | PFIZER INC. | PREVNAR - 13 (Biological) | Food and Beverage | In-kind items and services | $12.11 | General |
| Category: VACCINES | ||||||
| 01/06/2017 | Orexigen Therapeutics, Inc. | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: OBESITY | ||||||
| 01/04/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO (Drug) | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: RESPIRATORY | ||||||
| 01/03/2017 | Astellas Pharma US Inc | Myrbetriq (Drug), Vesicare | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: Urology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 3 | 234 | 267 | $77,669 | $17,187 |
| 2020 | 16 | 918 | 1,376 | $319,084 | $96,243 |
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 175 | 208 | $62,343 | $12,351 | 19.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 26 | 26 | $8,202 | $3,428 | 41.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 33 | 33 | $7,124 | $1,409 | 19.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 305 | 679 | $185,367 | $50,707 | 27.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 109 | 109 | $31,392 | $12,533 | 39.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 143 | 156 | $29,328 | $8,358 | 28.5% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 32 | 43 | $15,781 | $4,771 | 30.2% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 55 | 55 | $5,775 | $3,336 | 57.8% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2020 | 23 | 23 | $5,313 | $2,718 | 51.2% |
| 90670 | Pneumococcal vaccine for injection into muscle | Office | 2020 | 12 | 12 | $6,036 | $2,682 | 44.4% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 20 | 20 | $8,320 | $2,127 | 25.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 11 | 48 | $9,024 | $1,900 | 21.1% |
| 17110 | Destruction of up to 14 skin growths | Office | 2020 | 16 | 20 | $5,540 | $1,589 | 28.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 12 | 25 | $4,625 | $1,447 | 31.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 59 | 59 | $2,655 | $976.64 | 36.8% |
| 69210 | Removal of impact ear wax, one ear | Office | 2020 | 22 | 25 | $2,952 | $912.21 | 30.9% |
| G0180 | Physician certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial implem | Office | 2020 | 15 | 15 | $1,995 | $639.05 | 32.0% |
| G0180 | Physician certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial implem | Facility | 2020 | 16 | 17 | $2,261 | $587.06 | 26.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2020 | 35 | 35 | $1,575 | $576.98 | 36.6% |
| 83036 | Hemoglobin a1c level | Office | 2020 | 18 | 20 | $500.00 | $192.87 | 38.6% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 15 | 15 | $645.00 | $189.20 | 29.3% |
About Dr. Corey Evans, M.D
Dr. Corey Evans, M.D is a Family Medicine healthcare provider based in St Petersburg, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1790891182.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Corey Evans, M.D has received a total of $8,395 in payments from pharmaceutical and medical device companies, with $376.99 received in 2021. These payments were reported across 409 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($8,389).
As a Medicare-enrolled provider, Evans has provided services to 1,152 Medicare beneficiaries, totaling 1,643 services with total Medicare billing of $113,429. Data is available for 2 years (2020–2021), covering 21 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Geriatric Medicine, Sports Medicine
- Location St Petersburg, FL
- Active Since 08/21/2006
- Last Updated 10/01/2013
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1790891182
Products in Payments
- FARXIGA (Drug) $1,013
- Synthroid (Drug) $344.94
- ENTRESTO (Drug) $312.37
- INVOKANA (Drug) $295.17
- JARDIANCE (Drug) $264.23
- Santyl (Drug) $243.78
- Vascepa (Drug) $227.29
- TRULICITY (Drug) $210.83
- XIFAXAN (Drug) $205.74
- Apligraf (Biological) $204.36
- Trintellix (Drug) $203.18
- SYMBICORT (Drug) $198.18
- XARELTO (Drug) $188.93
- Ozempic (Drug) $168.32
- SPIRIVA RESPIMAT (Drug) $162.99
- BEVESPI AEROSPHERE (Drug) $157.88
- CHANTIX (Drug) $150.33
- TRELEGY ELLIPTA (Drug) $149.19
- Victoza (Drug) $144.58
- NAMENDA XR (Drug) $139.42
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in St Petersburg
Edward Braun, Md, MD
Family Medicine — Payments: $329,209
Dr. Roxana Stoici, Md, MD
Family Medicine — Payments: $228,936
Dr. Robert Wallace, Md, MD
Family Medicine — Payments: $151,311
Dr. Frederic Guerrier, M.d, M.D
Family Medicine — Payments: $45,706
Dr. Gigi Lefebvre, Md, MD
Family Medicine — Payments: $15,802
Dr. Daniel Eckstein, M.d, M.D
Family Medicine — Payments: $10,665